Clinical Trial Update: Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX) [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study of Nonafact (human coagulation factor IX) in patients with Hemophilia B has completed. The trial status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Nonafact (Factor IX)

Snippet

Sponsor: Prothya Biosolutions | Conditions: Hemophilia B | Phase 4 | Status: COMPLETED